English
简体中文
Total: £ 56.28
Published Date: 2026-01-30 | Pages: 101 | Tables: 98 | Pharma & Healthcare
The global Multivalent Oral Rotavirus Vaccine market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Multivalent Oral Rotavirus Vaccine competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
The multivalent oral rotavirus vaccine is specifically designed to prevent gastrointestinal infections caused by rotavirus. This vaccine effectively stimulates the immune system in children, reducing the risk of severe diarrhea, dehydration, and hospitalization, as rotavirus is a significant cause of gastroenteritis in infants and young children worldwide. Administered orally, it contains multiple attenuated or inactivated strains of the rotavirus, aiming to provide broad immune protection against different types of rotavirus.
The North American market for Multivalent Oral Rotavirus Vaccine is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The Asia-Pacific market for Multivalent Oral Rotavirus Vaccine is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
Major global manufacturers of Multivalent Oral Rotavirus Vaccine include Merck, Lanzhou Institute of Biological Products, Serum Institute of India, etc. In 2025, the world's top three vendors accounted for approximately % of revenue.
This report delivers a comprehensive overview of the global Multivalent Oral Rotavirus Vaccine market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Multivalent Oral Rotavirus Vaccine. The Multivalent Oral Rotavirus Vaccine market size, estimates, and forecasts are provided in terms of sales volume (K Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Multivalent Oral Rotavirus Vaccine market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Multivalent Oral Rotavirus Vaccine manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
Merck
Lanzhou Institute of Biological Products
Serum Institute of India
Segment by Type
RV3
RV5
by Application
Government Institution
Private Sector
Other
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for Multivalent Oral Rotavirus Vaccine manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines Multivalent Oral Rotavirus Vaccine sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Multivalent Oral Rotavirus Vaccine Market Overview
1.1 Product Definition
1.2 Multivalent Oral Rotavirus Vaccine by Type
1.2.1 Global Multivalent Oral Rotavirus Vaccine Market Value by Type: 2025 vs 2032
1.2.2 RV3
1.2.3 RV5
1.3 Multivalent Oral Rotavirus Vaccine by Application
1.3.1 Global Multivalent Oral Rotavirus Vaccine Market Value by Application: 2025 vs 2032
1.3.2 Government Institution
1.3.3 Private Sector
1.3.4 Other
1.4 Global Multivalent Oral Rotavirus Vaccine Market Size Estimates and Forecasts
1.4.1 Global Multivalent Oral Rotavirus Vaccine Revenue 2021–2032
1.4.2 Global Multivalent Oral Rotavirus Vaccine Sales 2021–2032
1.4.3 Global Multivalent Oral Rotavirus Vaccine Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Multivalent Oral Rotavirus Vaccine Market Competition by Manufacturers
2.1 Global Multivalent Oral Rotavirus Vaccine Sales Market Share by Manufacturers (2021–2026)
2.2 Global Multivalent Oral Rotavirus Vaccine Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Multivalent Oral Rotavirus Vaccine Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Multivalent Oral Rotavirus Vaccine, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Multivalent Oral Rotavirus Vaccine, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Multivalent Oral Rotavirus Vaccine, Product Types and Applications
2.7 Global Key Manufacturers of Multivalent Oral Rotavirus Vaccine, Date of Entry into the Industry
2.8 Global Multivalent Oral Rotavirus Vaccine Market Competitive Situation and Trends
2.8.1 Global Multivalent Oral Rotavirus Vaccine Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Multivalent Oral Rotavirus Vaccine Players Market Share by Revenue
2.8.3 Global Multivalent Oral Rotavirus Vaccine Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Multivalent Oral Rotavirus Vaccine Market Scenario by Region
3.1 Global Multivalent Oral Rotavirus Vaccine Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Multivalent Oral Rotavirus Vaccine Sales by Region: 2021–2032
3.2.1 Global Multivalent Oral Rotavirus Vaccine Sales by Region: 2021–2026
3.2.2 Global Multivalent Oral Rotavirus Vaccine Sales by Region: 2027–2032
3.3 Global Multivalent Oral Rotavirus Vaccine Revenue by Region: 2021–2032
3.3.1 Global Multivalent Oral Rotavirus Vaccine Revenue by Region: 2021–2026
3.3.2 Global Multivalent Oral Rotavirus Vaccine Revenue by Region: 2027–2032
3.4 North America Multivalent Oral Rotavirus Vaccine Market Facts & Figures by Country
3.4.1 North America Multivalent Oral Rotavirus Vaccine Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Multivalent Oral Rotavirus Vaccine Sales by Country (2021–2032)
3.4.3 North America Multivalent Oral Rotavirus Vaccine Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe Multivalent Oral Rotavirus Vaccine Market Facts & Figures by Country
3.5.1 Europe Multivalent Oral Rotavirus Vaccine Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Multivalent Oral Rotavirus Vaccine Sales by Country (2021–2032)
3.5.3 Europe Multivalent Oral Rotavirus Vaccine Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Multivalent Oral Rotavirus Vaccine Market Facts & Figures by Region
3.6.1 Asia Pacific Multivalent Oral Rotavirus Vaccine Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Multivalent Oral Rotavirus Vaccine Sales by Region (2021–2032)
3.6.3 Asia Pacific Multivalent Oral Rotavirus Vaccine Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Multivalent Oral Rotavirus Vaccine Market Facts & Figures by Country
3.7.1 Latin America Multivalent Oral Rotavirus Vaccine Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Multivalent Oral Rotavirus Vaccine Sales by Country (2021–2032)
3.7.3 Latin America Multivalent Oral Rotavirus Vaccine Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Multivalent Oral Rotavirus Vaccine Market Facts & Figures by Country
3.8.1 Middle East and Africa Multivalent Oral Rotavirus Vaccine Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Multivalent Oral Rotavirus Vaccine Sales by Country (2021–2032)
3.8.3 Middle East and Africa Multivalent Oral Rotavirus Vaccine Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Multivalent Oral Rotavirus Vaccine Sales by Type (2021–2032)
4.1.1 Global Multivalent Oral Rotavirus Vaccine Sales by Type (2021–2026)
4.1.2 Global Multivalent Oral Rotavirus Vaccine Sales by Type (2027–2032)
4.1.3 Global Multivalent Oral Rotavirus Vaccine Sales Market Share by Type (2021–2032)
4.2 Global Multivalent Oral Rotavirus Vaccine Revenue by Type (2021–2032)
4.2.1 Global Multivalent Oral Rotavirus Vaccine Revenue by Type (2021–2026)
4.2.2 Global Multivalent Oral Rotavirus Vaccine Revenue by Type (2027–2032)
4.2.3 Global Multivalent Oral Rotavirus Vaccine Revenue Market Share by Type (2021–2032)
4.3 Global Multivalent Oral Rotavirus Vaccine Price by Type (2021–2032)
5 Segment by Application
5.1 Global Multivalent Oral Rotavirus Vaccine Sales by Application (2021–2032)
5.1.1 Global Multivalent Oral Rotavirus Vaccine Sales by Application (2021–2026)
5.1.2 Global Multivalent Oral Rotavirus Vaccine Sales by Application (2027–2032)
5.1.3 Global Multivalent Oral Rotavirus Vaccine Sales Market Share by Application (2021–2032)
5.2 Global Multivalent Oral Rotavirus Vaccine Revenue by Application (2021–2032)
5.2.1 Global Multivalent Oral Rotavirus Vaccine Revenue by Application (2021–2026)
5.2.2 Global Multivalent Oral Rotavirus Vaccine Revenue by Application (2027–2032)
5.2.3 Global Multivalent Oral Rotavirus Vaccine Revenue Market Share by Application (2021–2032)
5.3 Global Multivalent Oral Rotavirus Vaccine Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Merck
6.1.1 Merck Company Information
6.1.2 Merck Description and Business Overview
6.1.3 Merck Multivalent Oral Rotavirus Vaccine Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Merck Multivalent Oral Rotavirus Vaccine Product Portfolio
6.1.5 Merck Recent Developments/Updates
6.2 Lanzhou Institute of Biological Products
6.2.1 Lanzhou Institute of Biological Products Company Information
6.2.2 Lanzhou Institute of Biological Products Description and Business Overview
6.2.3 Lanzhou Institute of Biological Products Multivalent Oral Rotavirus Vaccine Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Lanzhou Institute of Biological Products Multivalent Oral Rotavirus Vaccine Product Portfolio
6.2.5 Lanzhou Institute of Biological Products Recent Developments/Updates
6.3 Serum Institute of India
6.3.1 Serum Institute of India Company Information
6.3.2 Serum Institute of India Description and Business Overview
6.3.3 Serum Institute of India Multivalent Oral Rotavirus Vaccine Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Serum Institute of India Multivalent Oral Rotavirus Vaccine Product Portfolio
6.3.5 Serum Institute of India Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Multivalent Oral Rotavirus Vaccine Industry Chain Analysis
7.2 Multivalent Oral Rotavirus Vaccine Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Multivalent Oral Rotavirus Vaccine Production Mode & Process Analysis
7.4 Multivalent Oral Rotavirus Vaccine Sales and Marketing
7.4.1 Multivalent Oral Rotavirus Vaccine Sales Channels
7.4.2 Multivalent Oral Rotavirus Vaccine Distributors
7.5 Multivalent Oral Rotavirus Vaccine Customer Analysis
8 Multivalent Oral Rotavirus Vaccine Market Dynamics
8.1 Multivalent Oral Rotavirus Vaccine Industry Trends
8.2 Multivalent Oral Rotavirus Vaccine Market Drivers
8.3 Multivalent Oral Rotavirus Vaccine Market Challenges
8.4 Multivalent Oral Rotavirus Vaccine Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Multivalent Oral Rotavirus Vaccine Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global Multivalent Oral Rotavirus Vaccine Market Value by Application (US$ Million), 2025 vs 2032
Table 3. Global Multivalent Oral Rotavirus Vaccine Market Competitive Situation by Manufacturers in 2025
Table 4. Global Multivalent Oral Rotavirus Vaccine Sales (K Units) of Key Manufacturers (2021–2026)
Table 5. Global Multivalent Oral Rotavirus Vaccine Sales Market Share by Manufacturers (2021–2026)
Table 6. Global Multivalent Oral Rotavirus Vaccine Revenue (US$ Million) by Manufacturers (2021–2026)
Table 7. Global Multivalent Oral Rotavirus Vaccine Revenue Share by Manufacturers (2021–2026)
Table 8. Global Market Multivalent Oral Rotavirus Vaccine Average Price (US$/Unit) of Key Manufacturers (2021–2026)
Table 9. Global Key Players of Multivalent Oral Rotavirus Vaccine, Industry Ranking, 2023 vs 2024 vs 2025
Table 10. Global Key Manufacturers of Multivalent Oral Rotavirus Vaccine, Manufacturing Sites and Headquarters
Table 11. Global Key Manufacturers of Multivalent Oral Rotavirus Vaccine, Product Types and Applications
Table 12. Global Key Manufacturers of Multivalent Oral Rotavirus Vaccine, Date of Entry into the Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Multivalent Oral Rotavirus Vaccine Companies by Tier (Tier 1, Tier 2, Tier 3), based on Multivalent Oral Rotavirus Vaccine Revenue, 2025
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Multivalent Oral Rotavirus Vaccine Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 17. Global Multivalent Oral Rotavirus Vaccine Sales by Region (K Units), 2021–2026
Table 18. Global Multivalent Oral Rotavirus Vaccine Sales Market Share by Region (2021–2026)
Table 19. Global Multivalent Oral Rotavirus Vaccine Sales by Region (K Units), 2027–2032
Table 20. Global Multivalent Oral Rotavirus Vaccine Sales Market Share by Region (2027–2032)
Table 21. Global Multivalent Oral Rotavirus Vaccine Revenue by Region (US$ Million), 2021–2026
Table 22. Global Multivalent Oral Rotavirus Vaccine Revenue Market Share by Region (2021–2026)
Table 23. Global Multivalent Oral Rotavirus Vaccine Revenue by Region (US$ Million), 2027–2032
Table 24. Global Multivalent Oral Rotavirus Vaccine Revenue Market Share by Region (2027–2032)
Table 25. North America Multivalent Oral Rotavirus Vaccine Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 26. North America Multivalent Oral Rotavirus Vaccine Sales by Country (K Units), 2021–2026
Table 27. North America Multivalent Oral Rotavirus Vaccine Sales by Country (K Units), 2027–2032
Table 28. North America Multivalent Oral Rotavirus Vaccine Revenue by Country (US$ Million), 2021–2026
Table 29. North America Multivalent Oral Rotavirus Vaccine Revenue by Country (US$ Million), 2027–2032
Table 30. Europe Multivalent Oral Rotavirus Vaccine Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 31. Europe Multivalent Oral Rotavirus Vaccine Sales by Country (K Units), 2021–2026
Table 32. Europe Multivalent Oral Rotavirus Vaccine Sales by Country (K Units), 2027–2032
Table 33. Europe Multivalent Oral Rotavirus Vaccine Revenue by Country (US$ Million), 2021–2026
Table 34. Europe Multivalent Oral Rotavirus Vaccine Revenue by Country (US$ Million), 2027–2032
Table 35. Asia Pacific Multivalent Oral Rotavirus Vaccine Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 36. Asia Pacific Multivalent Oral Rotavirus Vaccine Sales by Region (K Units), 2021–2026
Table 37. Asia Pacific Multivalent Oral Rotavirus Vaccine Sales by Region (K Units), 2027–2032
Table 38. Asia Pacific Multivalent Oral Rotavirus Vaccine Revenue by Region (US$ Million), 2021–2026
Table 39. Asia Pacific Multivalent Oral Rotavirus Vaccine Revenue by Region (US$ Million), 2027–2032
Table 40. Latin America Multivalent Oral Rotavirus Vaccine Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 41. Latin America Multivalent Oral Rotavirus Vaccine Sales by Country (K Units), 2021–2026
Table 42. Latin America Multivalent Oral Rotavirus Vaccine Sales by Country (K Units), 2027–2032
Table 43. Latin America Multivalent Oral Rotavirus Vaccine Revenue by Country (US$ Million), 2021–2026
Table 44. Latin America Multivalent Oral Rotavirus Vaccine Revenue by Country (US$ Million), 2027–2032
Table 45. Middle East and Africa Multivalent Oral Rotavirus Vaccine Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 46. Middle East and Africa Multivalent Oral Rotavirus Vaccine Sales by Country (K Units), 2021–2026
Table 47. Middle East and Africa Multivalent Oral Rotavirus Vaccine Sales by Country (K Units), 2027–2032
Table 48. Middle East and Africa Multivalent Oral Rotavirus Vaccine Revenue by Country (US$ Million), 2021–2026
Table 49. Middle East and Africa Multivalent Oral Rotavirus Vaccine Revenue by Country (US$ Million), 2027–2032
Table 50. Global Multivalent Oral Rotavirus Vaccine Sales (K Units) by Type (2021–2026)
Table 51. Global Multivalent Oral Rotavirus Vaccine Sales (K Units) by Type (2027–2032)
Table 52. Global Multivalent Oral Rotavirus Vaccine Sales Market Share by Type (2021–2026)
Table 53. Global Multivalent Oral Rotavirus Vaccine Sales Market Share by Type (2027–2032)
Table 54. Global Multivalent Oral Rotavirus Vaccine Revenue (US$ Million) by Type (2021–2026)
Table 55. Global Multivalent Oral Rotavirus Vaccine Revenue (US$ Million) by Type (2027–2032)
Table 56. Global Multivalent Oral Rotavirus Vaccine Revenue Market Share by Type (2021–2026)
Table 57. Global Multivalent Oral Rotavirus Vaccine Revenue Market Share by Type (2027–2032)
Table 58. Global Multivalent Oral Rotavirus Vaccine Price (US$/Unit) by Type (2021–2026)
Table 59. Global Multivalent Oral Rotavirus Vaccine Price (US$/Unit) by Type (2027–2032)
Table 60. Global Multivalent Oral Rotavirus Vaccine Sales (K Units) by Application (2021–2026)
Table 61. Global Multivalent Oral Rotavirus Vaccine Sales (K Units) by Application (2027–2032)
Table 62. Global Multivalent Oral Rotavirus Vaccine Sales Market Share by Application (2021–2026)
Table 63. Global Multivalent Oral Rotavirus Vaccine Sales Market Share by Application (2027–2032)
Table 64. Global Multivalent Oral Rotavirus Vaccine Revenue (US$ Million) by Application (2021–2026)
Table 65. Global Multivalent Oral Rotavirus Vaccine Revenue (US$ Million) by Application (2027–2032)
Table 66. Global Multivalent Oral Rotavirus Vaccine Revenue Market Share by Application (2021–2026)
Table 67. Global Multivalent Oral Rotavirus Vaccine Revenue Market Share by Application (2027–2032)
Table 68. Global Multivalent Oral Rotavirus Vaccine Price (US$/Unit) by Application (2021–2026)
Table 69. Global Multivalent Oral Rotavirus Vaccine Price (US$/Unit) by Application (2027–2032)
Table 70. Merck Company Information
Table 71. Merck Description and Business Overview
Table 72. Merck Multivalent Oral Rotavirus Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 73. Merck Multivalent Oral Rotavirus Vaccine Product
Table 74. Merck Recent Developments/Updates
Table 75. Lanzhou Institute of Biological Products Company Information
Table 76. Lanzhou Institute of Biological Products Description and Business Overview
Table 77. Lanzhou Institute of Biological Products Multivalent Oral Rotavirus Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 78. Lanzhou Institute of Biological Products Multivalent Oral Rotavirus Vaccine Product
Table 79. Lanzhou Institute of Biological Products Recent Developments/Updates
Table 80. Serum Institute of India Company Information
Table 81. Serum Institute of India Description and Business Overview
Table 82. Serum Institute of India Multivalent Oral Rotavirus Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 83. Serum Institute of India Multivalent Oral Rotavirus Vaccine Product
Table 84. Serum Institute of India Recent Developments/Updates
Table 85. Key Raw Materials Lists
Table 86. Raw Materials Key Suppliers Lists
Table 87. Multivalent Oral Rotavirus Vaccine Distributors List
Table 88. Multivalent Oral Rotavirus Vaccine Customers List
Table 89. Multivalent Oral Rotavirus Vaccine Market Trends
Table 90. Multivalent Oral Rotavirus Vaccine Market Drivers
Table 91. Multivalent Oral Rotavirus Vaccine Market Challenges
Table 92. Multivalent Oral Rotavirus Vaccine Market Restraints
Table 93. Research Programs/Design for This Report
Table 94. Key Data Information from Secondary Sources
Table 95. Key Data Information from Primary Sources
Table 96. Authors List of This Report
List of Figures
Figure 1. Product Picture of Multivalent Oral Rotavirus Vaccine
Figure 2. Global Multivalent Oral Rotavirus Vaccine Market Value by Type (US$ Million), 2021–2032
Figure 3. Global Multivalent Oral Rotavirus Vaccine Market Share by Type: 2025 & 2032
Figure 4. RV3 Product Picture
Figure 5. RV5 Product Picture
Figure 6. Global Multivalent Oral Rotavirus Vaccine Market Value by Application (US$ Million), 2021–2032
Figure 7. Global Multivalent Oral Rotavirus Vaccine Market Share by Application: 2025 & 2032
Figure 8. Government Institution
Figure 9. Private Sector
Figure 10. Other
Figure 11. Global Multivalent Oral Rotavirus Vaccine Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 12. Global Multivalent Oral Rotavirus Vaccine Market Size (US$ Million), 2021–2032
Figure 13. Global Multivalent Oral Rotavirus Vaccine Sales (K Units), 2021–2032
Figure 14. Global Multivalent Oral Rotavirus Vaccine Average Price (US$/Unit), 2021–2032
Figure 15. Multivalent Oral Rotavirus Vaccine Report Years Considered
Figure 16. Multivalent Oral Rotavirus Vaccine Sales Share by Manufacturers in 2025
Figure 17. Global Multivalent Oral Rotavirus Vaccine Revenue Share by Manufacturers in 2025
Figure 18. Top 5 and Top 10 Global Multivalent Oral Rotavirus Vaccine Players: Market Share by Revenue in Multivalent Oral Rotavirus Vaccine in 2025
Figure 19. Multivalent Oral Rotavirus Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 20. Global Multivalent Oral Rotavirus Vaccine Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 21. North America Multivalent Oral Rotavirus Vaccine Sales Market Share by Country (2021–2032)
Figure 22. North America Multivalent Oral Rotavirus Vaccine Revenue Market Share by Country (2021–2032)
Figure 23. United States Multivalent Oral Rotavirus Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 24. Canada Multivalent Oral Rotavirus Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 25. Europe Multivalent Oral Rotavirus Vaccine Sales Market Share by Country (2021–2032)
Figure 26. Europe Multivalent Oral Rotavirus Vaccine Revenue Market Share by Country (2021–2032)
Figure 27. Germany Multivalent Oral Rotavirus Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 28. France Multivalent Oral Rotavirus Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 29. U.K. Multivalent Oral Rotavirus Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 30. Italy Multivalent Oral Rotavirus Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 31. Russia Multivalent Oral Rotavirus Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 32. Asia Pacific Multivalent Oral Rotavirus Vaccine Sales Market Share by Region (2021–2032)
Figure 33. Asia Pacific Multivalent Oral Rotavirus Vaccine Revenue Market Share by Region (2021–2032)
Figure 34. China Multivalent Oral Rotavirus Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 35. Japan Multivalent Oral Rotavirus Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 36. South Korea Multivalent Oral Rotavirus Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 37. India Multivalent Oral Rotavirus Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 38. Australia Multivalent Oral Rotavirus Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. China Taiwan Multivalent Oral Rotavirus Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. Southeast Asia Multivalent Oral Rotavirus Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. Latin America Multivalent Oral Rotavirus Vaccine Sales Market Share by Country (2021–2032)
Figure 42. Latin America Multivalent Oral Rotavirus Vaccine Revenue Market Share by Country (2021–2032)
Figure 43. Mexico Multivalent Oral Rotavirus Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 44. Brazil Multivalent Oral Rotavirus Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 45. Argentina Multivalent Oral Rotavirus Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 46. Colombia Multivalent Oral Rotavirus Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 47. Middle East and Africa Multivalent Oral Rotavirus Vaccine Sales Market Share by Country (2021–2032)
Figure 48. Middle East and Africa Multivalent Oral Rotavirus Vaccine Revenue Market Share by Country (2021–2032)
Figure 49. Turkey Multivalent Oral Rotavirus Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 50. Saudi Arabia Multivalent Oral Rotavirus Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 51. UAE Multivalent Oral Rotavirus Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 52. Global Sales Market Share of Multivalent Oral Rotavirus Vaccine by Type (2021–2032)
Figure 53. Global Revenue Market Share of Multivalent Oral Rotavirus Vaccine by Type (2021–2032)
Figure 54. Global Multivalent Oral Rotavirus Vaccine Price (US$/Unit) by Type (2021–2032)
Figure 55. Global Sales Market Share of Multivalent Oral Rotavirus Vaccine by Application (2021–2032)
Figure 56. Global Revenue Market Share of Multivalent Oral Rotavirus Vaccine by Application (2021–2032)
Figure 57. Global Multivalent Oral Rotavirus Vaccine Price (US$/Unit) by Application (2021–2032)
Figure 58. Multivalent Oral Rotavirus Vaccine Value Chain
Figure 59. Channels of Distribution (Direct Vs Distribution)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
